93 related articles for article (PubMed ID: 4447018)
1. [Stability of drugs in lyophilic suppository bases. V. Identification of products of ethionamide decay isolated from suppositories].
Cieszyński T
Acta Pol Pharm; 1974; 31(5):651-6. PubMed ID: 4447018
[No Abstract] [Full Text] [Related]
2. [Stability of drugs in lyophilic suppository bases. IV. Identification of decomposition products of cyclovegantine isolated from suppositories].
Cieszyński T
Acta Pol Pharm; 1974; 31(1):99-107. PubMed ID: 4151652
[No Abstract] [Full Text] [Related]
3. Study on stability of drugs in lyophilic suppository bases. 3. Isolation of cyclovegantine, ethionamide and euphyllin degradation products from suppositories.
Cieszyński T
Acta Pol Pharm; 1972; 29(1):75-83. PubMed ID: 5055291
[No Abstract] [Full Text] [Related]
4. [Drug stability in lyophilic suppository media].
Cieszyński T
Acta Pol Pharm; 1974; 31(2):257-8. PubMed ID: 4840677
[No Abstract] [Full Text] [Related]
5. [Drug stability in lyophilic suppository bases. VI. Identification of euphylline decay products isolated from suppositories].
Cieszyński T
Acta Pol Pharm; 1975; 32(3):371-7. PubMed ID: 1155194
[No Abstract] [Full Text] [Related]
6. [Studies on the stability of drugs in lyophilic suppository media. II. Evaluation of decay of cyclovegantine, ethionamide and euphylline in suppositories].
Cieszyński T
Acta Pol Pharm; 1971; 28(4):375-84. PubMed ID: 5145789
[No Abstract] [Full Text] [Related]
7. [Studies on stability of drugs in lyophilized suppository bases. 1. Separation and detection of products of decomposition of cyclovegantine, ethionamide and euphylline by means of thin-layer chromatography].
Cieszyński T
Acta Pol Pharm; 1971; 28(1):59-69. PubMed ID: 5577813
[No Abstract] [Full Text] [Related]
8. [Kinetics of drug decay. 28. Photolytic decomposition of ethionamide salts].
Pawelczyk E; Domeracki S
Acta Pol Pharm; 1974; 31(3):315-22. PubMed ID: 4849030
[No Abstract] [Full Text] [Related]
9. Suppositories containing beta-cyclodextrin complexes. Part 1: Stability studies.
Szente L; Apostol I; Szejtli J
Pharmazie; 1984 Oct; 39(10):697-9. PubMed ID: 6522449
[TBL] [Abstract][Full Text] [Related]
10. [Kinetics of drug degradation. VI. Kinetics of degradation of phenylbutazone (FB) in suppository bases].
Pawelczyk E; Zajac M
Acta Pol Pharm; 1970; 27(2):113-7. PubMed ID: 5422244
[No Abstract] [Full Text] [Related]
11. [Kinetics of drug decay. XXVII. Solvolysis of some ethionamide salts].
Pawelczyk E; Domeracki S
Acta Pol Pharm; 1974; 31(3):305-13. PubMed ID: 4849029
[No Abstract] [Full Text] [Related]
12. [Applicability of densitometry procedures to the study of polymorphic transformation of triglyceride suppository size].
Hüttenrauch R; Möller U
Pharmazie; 1985 Aug; 40(8):582-3. PubMed ID: 4080812
[No Abstract] [Full Text] [Related]
13. [Choice of bases for suppositories with antibiotics. I. Stability of antibiotics in suppository bases].
Zaremba A; Krówczyński L
Acta Pol Pharm; 1974; 31(6):769-73. PubMed ID: 4447038
[No Abstract] [Full Text] [Related]
14. Effect of surfactant incorporation techniques on sulphamethoxazole suppository formulations.
Abd el-Gawad AH; el-Din EZ; Abd el-Alim HA
Pharmazie; 1988 Sep; 43(9):624-7. PubMed ID: 3244731
[TBL] [Abstract][Full Text] [Related]
15. [The stability of papaverine. 1. Qualitative identification of secondary papaverine degradation products].
Gundermann P; Pohloudek-Fabini R
Pharmazie; 1978 Apr; 33(4):205-7. PubMed ID: 674315
[No Abstract] [Full Text] [Related]
16. Quantitative analysis of pharmaceutical preparations by x-ray diffractometry. X. Direct quantitative x-ray diffraction analysis of ethionamide in rectal suppositories.
Kuroda K; Hashizume G
Chem Pharm Bull (Tokyo); 1972 Sep; 20(9):2059-62. PubMed ID: 4645224
[No Abstract] [Full Text] [Related]
17. [Control of the acceptability and stability of proprietary drugs].
Braidotti L; Crivellaro GB
Farmaco Prat; 1968 Oct; 23(10):509-41. PubMed ID: 5721577
[No Abstract] [Full Text] [Related]
18. [Physical stability of suppository bases at different temperatures].
Leszczyńska-Bakal H
Acta Pol Pharm; 1971; 28(5):531-5. PubMed ID: 5145101
[No Abstract] [Full Text] [Related]
19. [Changes in physiochemical properties of shelved oleaginous suppository bases: the effects on indomethacin, aminopyrine and sulpyrine release rates].
Ejima A; Tatsuzawa M; Ogata H; Aoyagi N; Kaniwa N; Matsuda R
Eisei Shikenjo Hokoku; 1983; (101):75-9. PubMed ID: 6675777
[No Abstract] [Full Text] [Related]
20. Stabilization of AD-1590, a non-steroidal antiinflammatory agent, in suppository bases by beta-cyclodextrin complexation.
Takahashi T; Kagami I; Kitamura K; Nakanishi Y; Imasato Y
Chem Pharm Bull (Tokyo); 1986 Apr; 34(4):1770-4. PubMed ID: 3487392
[No Abstract] [Full Text] [Related]
[Next] [New Search]
